| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3979620 | Bulletin du Cancer | 2010 | 5 Pages |
Abstract
We describe herein the current concepts tested in clinical trials dedicated to patients with metastatic soft tissue sarcomas: identify predictive factors under anthracyclin-based regimens, identify patients beneficing from polychemotherapy, benefit of maintenance treatment, use of non-progression rate rather than response rate for selecting new drugs, histology-tailored or biological target-tailored second-line treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N. Penel, F. Watelle, M. Vanhuyse, A. Adenis,